NSIM
EVH icon

North Star Investment Management’s Evolent Health EVH Stock Holding History

North Star Investment Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.06K Buy
380
+215
+130% +$824 ﹤0.01% 1421
2026
Q1 		$376 Buy
+165
New +$523 ﹤0.01% 1661

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

North Star Investment Management's EVH Position: Q2 2026 in Review

North Star Investment Management increased its Evolent Health (EVH) stake by 130% in Q2 2026, buying an estimated $824 and bringing the position to 380 shares worth $2.06K. The position accounts for ﹤0.01% of the portfolio, ranked #1421.

North Star Investment Management first reported a position in EVH in Q1 2026 and has held it in 2 quarters since. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • North Star Investment Management held 380 shares of Evolent Health worth $2.06K as of Q2 2026.
  • North Star Investment Management bought 215 Evolent Health shares in Q2 2026, an estimated $824.
  • Evolent Health made up ﹤0.01% of North Star Investment Management's portfolio in Q2 2026, its #1421 holding.
  • North Star Investment Management first reported a position in Evolent Health in Q1 2026 and has held it in 2 quarters since.
  • 198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on North Star Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.